Kineta, Inc.
14Patents
14Active
14Granted
56Portfolio score
Filing activity: Apr 20, 2011 → Nov 18, 2022 · 3 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8895608B2 | Sulfonamide anti-viral compounds | Chemistry; Metallurgy | 5 | Active |
| US9884876B2 | Anti-viral compounds, pharmaceutical compositions, and methods of use thereof | Emerging Cross-Sectional Technologies | 3 | Active |
| US9073946B2 | Anti-viral compounds | Emerging Cross-Sectional Technologies | 3 | Active |
| US9408826B2 | Isoflavone anti-viral compounds | Chemistry; Metallurgy | 3 | Active |
| US9301952B2 | Diarylpyridine anti-viral compounds | Emerging Cross-Sectional Technologies | 1 | Active |
| US9555106B2 | Anti-viral compounds | Emerging Cross-Sectional Technologies | 0 | Active |
| US8927561B2 | Pyrimidinedione anti-viral compounds | Human Necessities | 0 | Active |
| US9956285B2 | Anti-viral compounds | Emerging Cross-Sectional Technologies | 0 | Active |
| US8871799B2 | Iminochromene anti-viral compounds | Chemistry; Metallurgy | 0 | Active |
| US12180189B2 | Proteostasis regulators | Chemistry; Metallurgy | 0 | Active |
| US9115065B2 | Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with Arenaviruses | Emerging Cross-Sectional Technologies | 0 | Active |
| US11958873B2 | Proteasome activity enhancing compounds | Chemistry; Metallurgy | 0 | Active |
| US9458492B2 | Methods and cells for identifying RIG-I pathway regulators | Emerging Cross-Sectional Technologies | 0 | Active |
| US12319698B2 | Proteasome activity enhancing compounds | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.